Michael Porubcin, M.D.

Phone Number:

(309) 779-4265

Specialty:

Hematology/Oncology

Education:

Comenius University, Slovak Republic - Medical School

Memorial Sloan Kettering Cancer Center - Cell Biology & Genetics and Molecular Pharmacology & Chemistry Program

University of South Alabama - Internal Medicine Residency, Hematology/Oncology Fellowship

MD Anderson Cancer Center - Department of Stem Cell Transplantation & Cellular Therapy

Certifications:

Board Certified in Hematology

Board Certified in Medical Oncology

Memberships:

American Society of Clinical Oncology (ASCO)

American Society of Hematology (ASH)

Catholic Medical Association (CMA)

Appointments:

Laboratory Director - Medical Arts Associates, Ltd. (2000-Present)

Medical Director - Oncology Services, UnityPoint Health-Quad Cities (2015 - 2017)

Hospital Affiliations:

Unity Point Health - Trinity Rock Island, Moline and Bettendorf Campus

Genesis Medical Center Illini Campus

Clinical Research Affiliations:

Cancer Trials Support Unit (CTSU)

Outside Interests:

Spending time with family and friends. Love reading and playing tennis.

Publications:

1. Garrick MD, Dolan KG, Horbinski C, Ghio AJ, Higgins D, Porubcin M, Moore EG, Hainsworth LN, Umbreit JN, Conrad ME, Feng L, Lis A, Roth JA, Singleton S, Garrick LM: DMT1: a mammalian transporter for multiple metals. Biometals, Review, 2003 March; 16(1): 41-54.

2. Marcel E. Conrad, Jay N. Umbreit, Elizabeth G. Moore, Lucille N. Hainsworth, Michael Porubcin, Marcia J. Simovich, Marian T. Nakada, Kevin Dolan, and Michael D. Garrick: Separate pathways for cellular uptake of ferric and ferrous iron. Am J Gastrointest Liver Physiol 2000 Oct; 279 (4):G767-74.

3. Otrusinik R, Alpert MA, Hamm CR, Bikkina M, Porubcin M, Panayiotou H: Factors predicting coronary artery disease in patients with giant negative T waves. Am J Cardiol. 2000 April 1; 85(7):873-5, A9.

4. Ross RA, Spengler BA, Domenech C, Porubcin M, Rettig WJ, and Biedler JL (1994): Human Neuroblastoma I-Type Cells are Malignant Neural Crest Stem Cells. Cell Growth Differ April 1995; 6(4):449-56.

5. Spengler BA, Domenech C, Porubcin M, Biedler JL: Human Neuroblastoma Lines Respond Differently to Diverse Differentiation-Inducing Agents. In Evans AE, Biedler JL, Brodeur GM, D'Angio GJ, and Nakagawara A (eds): "Advances in Neuroblastoma Research 4. New York: Wiley-Liss, Inc., 1994; pp 261-267.

6. Biedler JL, Chang TD, Druskin H, Meyers MB, Porubcin M, Spengler BA: Rapid Elimination of P-glycoprotein-encoding Genes After Exposure of Vincristine-resistant Chinese Hamster Lunc Gells, DC-3F/VCR-5L, to Verapamil. Gen. Motors Cancer Res. Found. Int. Symp., Toronto, Canada, May 6-8, 1993.

7. Chang YM, Aschele CS, Porubcin M, Bertino JR: Sensitivity of Two Fluorouracil Resistant HCT-8 cell Lines to Fluorouridine (FUR), Methotrexate (MTX) and D1694, a Folate Inhibitor of Thymidylate Synthase. Proc. Amer. Cancer Res. 33:543, 1992.